查看文章

Objective To estimate the level of funding for neuroscience research from federal and industry sources and to examine the therapeutic advances in the neurosciences over the past decade. Methods We examined financing for neuroscience research over the past decade from the following principal sponsors of biomedical research: the National Institutes of Health, the pharmaceutical industry, large biotechnology firms, and large medical device firms. We also examined US Food and Drug Administration approvals for new molecular entities and medical devices for indications within the neurosciences. Neuroscience was defined to include funding and approvals for neurological and psychiatric conditions. Results Total (nominal) industry and government funding for neuroscience research increased from 4.8billionin1995to 14.1 billion in 2005 and doubled after adjusting for inflation. In 2005, the pharmaceutical …